Background: We reviewed 104 consecutive deaths of veterans receiving care in the Dayton VA Medical Center from October 10, 2015 to April 11, 2016. The purpose of our study was to test our hypothesis that palliative care consultation would be associated with reduced health care resource utilization for individuals approaching end of life. Methods: Medical records were reviewed and data entry recorded on a spreadsheet. Non-parametric statistical methods were used to compare four outcome variables from veterans with palliative care consultation (PCC) vs. those without PCC. These variables included the number of ED visits, hospitalizations, hospital days, and ICU days all during the last two months of life. Predictor variables included PCC vs. no PCC and PCC before vs. PCC during the last two months of life. The study sample was comprised of 102 patients after excluding two outlier cases with ethical challenges in surrogate decision-making. Results: Of the 102 consecutive veteran deaths, palliative care consultation was associated with a lower number of ICU days during the last two months of life. For 96 veterans with PCC, the frequency of ED visits and acute care hospitalizations, as well as the number of ICU and hospital days, were all significantly less after PCC compared to before PCC during the last two months of life. The timing of PCC had no effect on the outcomes of interest. Conclusion: Palliative care consultation has a notable effect on health care resource utilization during the last two months of life.
Introduction
Commenting on differing views of death and dying, Morrison said: ''The Scots see death as imminent. Canadians see death as inevitable. And Californians see death as optional.'' 1(p1) Many Americans are uncomfortable with their mortality as evidenced by a minority with living wills, general discomfort in discussing death, and the persistent prevalence of medicalized deaths-people dying uncomfortably in hospitals while receiving aggressive medical care in the last days of life. Despite worldwide surveys indicating more than 80% of people prefer to die at home, more than 50% actually die in hospitals. 2 Smith reports 50% of older Americans presenting to the emergency department (ED) in the last month of life with 50% of those individuals admitted and ultimately dying in the hospital. 3 Teno observes an increasing number of Medicare patients receiving intensive care unit (ICU) care in the last month of life and more than 25% of those dying in hospice care having received hospice for less than 3 days. 4 Palliative Care-An Alternative Approach to Care at End of Life
The goal of palliative care (PC) is to provide relief of symptoms and associated suffering from life-limiting disease. Improvement in quality of life and its physical, psychological, social, and spiritual dimensions is the intended outcome. 5 In this context, medical care is optimally delivered by an interdisciplinary team comprised of a physician, nurse practitioner or nurse, social worker, and chaplain with additional professionals as needed.
Palliative care is provided in both inpatient hospital and outpatient community settings. Hospice care, a distinct entity within the PC spectrum, focuses on comfort and is funded by a separate Medicare benefit, state Medicaid, and private insurance programs for individuals suffering from a life-limiting illness with life expectancy estimated to be 6 months or less.
Business Case for PC
Until recently, health-care services have been reimbursed solely on a revenue-focused fee-for-service model with incentives to maximize the volume of services measured in productivity-that is, the more the better. However, PC is focused on a ''less is more philosophy'' with a premium on patient preferences and quality of life. Palliative care often leads to reduced hospitalizations, hospital length of stays, ICU admissions/ length of stays, imaging studies, laboratory tests, diagnostic procedures, and invasive therapies. The business case for PC is measured in terms of patient satisfaction, cost avoidance, and quality metrics such as mortality and 30-day hospital readmission rates. The newly enacted Medicare Access and Children's Health Insurance Plan Reauthorization Act 2015 law will begin to move reimbursement from the Center for Medicare and Medicaid Services (CMS) toward value-based purchasing and alternative payment models. These new models will reward quality outcomes, efficiency, and patient satisfaction. 6 The resultant payment reforms will optimize financial alignment of health-care systems with PC services.
Hospitalizations and ED visits increase in frequency and cost toward the end of life. Cassel and colleagues report a negative fiscal outcome for Medicare patients hospitalized in the last 2 months of life. 7 They show impressive cost savings accruing to hospitals from decreased intensity of care due to PC inpatient consultation. Their calculated return on investment of 500% represents cost savings equal to 5 times the sum of the cost of the interdisciplinary team minus payer reimbursement. The CMS payment reform will apply penalties based on quality metrics, with 1% to 9% deductions for all diagnosis-related group payments annually. These penalties could have a significant budgetary impact on hospital systems.
The economic case for outpatient community PC is framed in cost avoidance such as preventing unnecessary ED visits and hospitalizations with financial benefit accruing to payers-CMS and insurance companies. A provider-payer partnership would be the ultimate beneficiary of a fully integrated PC program. 8, 9 Inpatient Hospital PC Consultation
In the United States, 61% of the hospitals with 50 or more beds and 90% with 300 or more beds now have a PC consultation (PCC) service. 10, 11 Due to the paucity of specialty PC physicians, many hospital PCC teams are led by a nurse practitioner or nurse. The goals of the consultation are to clarify care including code status, to consider moving the patient from curative to comfort-focused care, to evaluate for referral to hospice or withdrawal of life-sustaining treatment for terminally ill patients, and to manage symptoms. Meier describes 5 indications to refer patients for palliative medicine consultation: (1) stage IV solid tumor malignancy, (2) stage III pancreas or liver cancer, (3) uncontrolled physical or emotional symptoms, (4) more than 2 hospitalizations in the previous 6 months, and (5) presence of family distress. 11(p54) Strong evidence associates PCC with improvement in the quality of care, lower costs of care, effective clarification in goals of care, enhanced coordination of care in fragmented health systems, support for patients and families struggling with complex decisions, support of attending physicians in symptom management, improved patient and family satisfaction, reduced hospital mortality, and reduced 30-day readmissions. 12 Morrison reports direct cost savings from PCC of US$1696 per admission and US$174 per day in 8 hospitals. Extrapolating these data to the average 400-bed community hospital, the net annual savings would translate to US$1.3 million. 13 In a study of Medicaid patients in 4 New York hospitals, Morrison reports a reduction of US$4098 in hospital costs for patients discharged alive and US$7563 who died.
14 Assuming PCC for 2% to 6% of hospital admissions, Siu estimates an annual savings from US$84 million to US$252 million for the New York state Medicaid budget from hospital PCCs. 15 In an observational study of 7 hospitals, Bharadwaj reports PCC associated with 5.1 fewer hospital days, 40% cost reduction, 10% mortality decrease, and 61% decrease in 30-day readmissions. Overall, cost avoidance is 1.5 times the total cost of the PC programs. 16 O'Connor shows a PCC associated with 5% reduction in 30-day readmission rates compared to usual care in a large urban academic medical center. 17 In a prospective cohort study of patients with advanced cancer in 5 academic medical centers, May reports a 24% reduction in direct costs when PCC occurred within 2 days of admission and 14% within 6 days. 18 Additionally, in a review of 10 studies in the United States and Europe, May shows hospital cost savings of 9% to 25% associated with PCC. These cost savings are attributable to a reduction in laboratory and imaging studies, pharmacy expenditures, length of stay, and ICU days of care. 19 Nathanial reports savings of US$240 per day in hospital care when patients are transferred to a dedicated PC unit compared with patients being followed by the PC consult service. 20 
Outpatient Community PC
While much less common relative to hospital consultation, outpatient community PC is growing steadily in the United States. It is reasonable to assume that greater benefits could be realized by earlier PCC for individuals with life-limiting disease such as cancer, heart failure, chronic obstructive pulmonary disease (COPD), end-stage liver disease, and chronic neurological disease. In a landmark study, Temel reports 151 patients with newly diagnosed metastatic non-small cell lung cancer randomized to oncological care alone or to oncological care plus outpatient PC at monthly intervals until death. The PC group experienced a better quality of life with less aggressive care, fewer depressive symptoms, and a longer median survival of 2.7 months compared to the usual oncology care group. 21 In a recent report, King validates Temel's findings in an observational study, showing a survival advantage of 1.8 months for 207 patients with advanced cancer who had early PC in addition to oncological care. 22 The American Society of Clinical Oncology recommends early PC in the treatment of patients with cancer, '' . . . combined standard oncology care, PC should be considered early in the course of illness for any patient with metastatic cancer and/or high symptom burden.'' 23(p884) In a review of 4 randomized interventions testing the impact of outpatient PC, Rabow reports that outpatient PC can improve patient satisfaction, symptom control and quality of life, reduce health-care utilization, and lengthen survival of patients with lung cancer. 24 
Dayton Veterans Affairs Medical Center PC Program
The Dayton Veterans Affairs Medical Center (VAMC) has an integrated PC program established in 1998 (G.K. and K.H.) with an active hospital consultation service, a dedicated 22-bed inpatient hospice unit managed by a committed interdisciplinary hospice staff, and a PC outpatient clinic. The PC and oncology clinics are colocated, which facilitates collaboration between services including fellows from Boonshoft School of Medicine, Wright State University. The palliative medicine fellowship director (G.K.) is also chief of oncology at the Dayton VAMC. Ohio's Hospice of Dayton is our community partner and a national leader in innovative hospice and PC providing inpatient, clinic, and home hospice care. Hospice of Dayton physicians are active faculty members in the palliative medicine fellowship program (note 1).
Study Objective
The purpose of our study was to determine the influence of PCC provided in the hospital or outpatient clinic on the intensity of health-care resource utilization by veterans during the final 2 months of life. Our hypothesis was that PCC would reduce health-care resource intensity, as veterans approach the end of life.
Methods
A retrospective medical record review of consecutive deaths at the Dayton VAMC over a 6-month period from October 10, 2015, to April 11, 2016 , yielded a cohort of 104 veterans. All medical care activity during the last 2 months of life was recorded using an Excel spreadsheet. Predictor variables were PCC versus no PCC before and during the last 2 months, respectively. Outcome variables were ED visits, hospitalizations, ICU length of stay, and hospital length of stay before and after PCC. Two veterans were excluded as outliers in hospital length of stay (235 and 126 days) due to ethical challenges in surrogate decision-making, which confounded the association between predictor and outcome variables in each case. Thus, the sample size was 102 patients.
Statistical analysis (R.J.M.) was done with IBM SPSS Statistics 23.0 (IBM, Armonk, New York). Since outcomes measured on a continuous scale were not normally distributed, the independent samples Mann-Whitney U test was used for comparisons involving the PCC and no PCC groups and KruskalWallis test was used to compare the PCC group before and after consultation. 
Results
Of 2689 acute care admissions during the study period, there were 163 new PCCs for a penetration rate of 6.1%. There were 104 deaths at the Dayton VAMC during the study period. One hundred two veterans composed our study group after excluding the 2 outliers mentioned above. Table 1 shows the distribution of terminal diagnoses for the 102 veterans. Of the 102 veterans, 99 were males and 3 females. The mean age at death was 76 years. Ninety-six (94%) of the 102 participants had PCC. The mean number of days from PCC to death was 24 days. Of the 96 veterans with PCC, 90 were subsequently admitted to the inpatient hospice unit where they died with a mean length of stay of 11 days. Fifty-one patients (50%) had advance directives. Table 2 shows the medical care outcomes during the last 2 months of life for the 96 patients receiving PCC and 6 patients not receiving PCC. The PCC group had fewer ICU days (3.74 + 12.02 vs 11.33 + 14.83). The 2 groups did not differ in hospital days, ED visits, and hospitalizations. Table 3 shows the decrease in mean number of medical care outcomes before and after PCC. Emergency department visits, hospital admissions, hospital days, and ICU days were notably lower after PCC (P < .001). This dramatic decrease in the intensity of care after PCC suggests a change in focus to comfort-based care and enhanced quality of life for patients nearing the end of life. Palliative care consultants provide patients and family members needed validation and encouragement to justify comfort care when cure is no longer possible. Table 4 shows no difference in outcomes with regard to timing of PCC-2 months or less before death (n ¼ 88) versus more than 2 months before death (n ¼ 8).
Discussion
This study supports the value of our integrated PC program at the Dayton VAMC as evidenced by a high rate of PCC associated with a reduction in the intensity of care and referral to hospice care for our veterans with life-limiting disease. During the last 2 months of life, our veterans had significantly fewer acute care hospitalizations, ICU and hospital days of care, and ED visits after PCC compared to the period before PCC. Whether the PCC occurred before or during the last 2 months of life had no bearing on the medical care outcomes.
Of 102 consecutive deaths over a 6-month period, 96 veterans received a PCC, and 90 were subsequently admitted to the inpatient hospice unit where they died a peaceful death in comfort. The mean number of days from PCC until death was 24 days, and the average length of stay on the inpatient hospice unit totaled 11 days. Cancer was the terminal diagnosis for 68 veterans (67% of cohort), with none given chemotherapy during the last 2 weeks of life. Several of these veterans underwent limited radiation therapy for relief of pain.
We define integration of PC on 2 dimensions, vertical and horizontal. Vertical integration provides services across the continuum of care: inpatient PCC, outpatient PC clinic, inpatient hospice care, and home hospice care. Horizontal integration is evidenced by close collaboration between clinical services such as PC and oncology. As a result of close collaboration with the oncology service, a patient with cancer is referred early in his oncological care for PC support ''upstream'' when functional status is higher and disease often less advanced. By establishing a relationship with the patient early in his cancer care, we provide the necessary support with symptom management and address social, psychological, and spiritual needs so important to patients and their families.
Kamal reports that prevention of the crises resulting in avoidable hospitalizations helps patients with cancer complete their course of treatment and live longer. 25 However, chemotherapy for patients with end-stage cancer who have not responded to earlier lines of treatment is associated with higher end-of-life costs with limited benefit and poor quality of life in the week before death. 26 The transition to comfort-focused medical care can be facilitated in a less traumatic and more timely fashion when the PC service is following patients with end-stage cancer or end-organ failure. Despite the clinical, economic, and quality of life benefits of early PC at end of life for patients with cancer, PC services remain underutilized. 27 An integrated PC program across the continuum of care improves patient quality of life and experience of care while reducing the costs of low yield, ineffective care. In addition, early provision of PC improves clinical outcomes and lowers the costs of care for patients with advanced cancer and advanced stages of COPD, congestive heart failure (CHF), and multiple sclerosis. 28 In a systematic review of the literature on the integration of PC, Hui identifies 38 clinical, educational, and research indicators of integration such as an outpatient PC clinic, the presence of inpatient PCC teams, the presence of inhome PC, and a PC clinic embedded in oncology clinics. These authors make the point that integration is more than an outpatient clinic: '' . . . the comprehensiveness of the interdisciplinary team, the level of availability, and the degree of collaboration with the oncology team in the delivery of patient care . . . are all important.'' 29(p81) In a study of PC integrated with oncology, Muir shows PC physicians embedded in oncology offices saved oncologists an estimated 170 minutes per referral over the course of the patient-oncologist relationship or over 4 weeks per year per participating practice. 30 In a prospective, randomized controlled trial of in-home PC for patients with late-stage COPD, CHF, and cancer, Brumley reports significant improvement in patient satisfaction, fewer ER visits and hospitalizations, and a 45% reduction in total care costs, or 33% per patient. 31 To quote Kamal et al, ''patients deserve both focused attention to the science of reducing the burden of cancer, along with vigorous interest in improving the cancer experience through palliative care.'' 32 Less time in a hospital and lower intensity of medical care will translate to higher quality end of life and patient satisfaction with implicit cost savings. 33 
Limitations
A notable limitation of this study was the paucity of documentation for health-care episodes occurring in the community outside the Dayton VAMC. Consequently, we may have underestimated the frequency of health-care episodes for some of the patients in this study.
Due to the measurement variation of outcomes in our study population at the end of life, our data were not ideal for statistical analysis. First, since PCC occurred frequently in the study cohort (94%), the comparison group of 6 veterans was small in number. Second, the 4 outcomes were highly variable. For example, of the 102 index patients, 62 had hospital stays of 1 week or less while 14 had stays of 3 weeks or more, producing a large coefficient of variation (ie, standard deviation/ mean) of 3.48 (5.92/1.70). Although we obtained trustworthy P values by using nonparametric statistical tests, it is difficult to generalize our mean values for the 4 outcomes to other settings due to the small sample size in the small comparison group without PCC and large variability in all outcome measures. Also, a skewed gender distribution reflective of a VA patient population (99 males and 3 females) poses an additional challenge to the external validity of this study.
Conclusion
In an observational study of 102 consecutive deaths of veterans in a VAMC, PCC was associated with a lower number of ICU days during the last 2 months of life. For 96 veterans with a PCC, the frequency of ED visits and acute care hospitalizations as well as the number of ICU and hospital days were all significantly less after PCC compared to before PCC during the last 2 months of life.
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